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Becausegeneticaly baseddiseaseshaveamajorinpactonhumanhealth, theNational InstituteofEnvironmental Health
Sciences (NIEHS) hasconductedaresearchandtestingprogram formorethanadecade to addresschemicalinduction
ofheritablegeneticdamageinthegermcellsofmammals. Althoughmostgeneticdiseaseresultsfrompreexistingmuta-
tions, aportionisduetotheoccurrenceofnewmutations. Thesuppositionthatexposuretomutagenicc scontributes
totheoccurrenceofnewmutationsinthehumanpopulationisstronglysupportedbytheresultsfromanimalmodels. Such
studiesclearlydemonstratethepotentialofemnironmentalchemicalstoinducemutationsinbothsomaticandreproductive
cellsofmammals. ThisNIEHS programhasbecomealeaderintheidentificationofgenetic hazardsintheenvironment
and in theacquisition ofanimal model data used by regulatory agenciesinassessing genetic risks tohuman health.
The Human Health Issue
Genetically based diseases have a major impact on human
health. Of the nearly 5000 human gene loci exhibiting char-
acteristics of Mendelian inheritance (1) (Table 1), many are
associated with somedegreeofhealthdisorder. Althoughthefre-
quency ofany singlegeneticdisease islow, thetotalincidenceof
genetic disorders makes a significant impact on human health
(2-5) (Table 2). Further, decreased infantmortalitydue to reduc-
tions in the toll ofnutritional and infectious diseases has led to
an increase inthecontributionofgenetic disorderstotheoverall
human disease burden (9).
It has been estimated that 1% of liveborn infants express a
single gene disorder and that as many as 0.6% are born with a
majorchromosomeabnormality. Anadditional 1% maymanifest
a serious genetic disordersometime afterbirth. Emphasizing the
impactofgeneticdisease onchildhoodhealthistheestimate(10)
thatnearly 10% ofpediatrichospitaladmissions in NorthAmeri-
ca are for careand treatmentofgeneticdisorders. Ahigher pro-
portion ofhumans may exhibit late-onset disorders associated
with polygenic traits as aresultofpreexisting or new mutations
in any one of several genes. These mutations may lead to
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Table 1. Numberofhuman geneloci identifiedin
McKusick's Ninth Edition (1).
Mode ofinheritance No. ofloci
Autosomal dominant 1864 (1183)'
Autosomal recessive 631 (923)
X-Linked 161 (175)
Total 2656 (2281)
aAdditional loci not fully identified or validated in parentheses.
Table2. Incidenceofgenetic diseases inhuman newborns (6-8).
Mode ofinheritance Incidence per 1000 newborns
Autosomal dominant 1.4-10
X-Linked 0.4-0.8
Recessive 1.7-2.5
Multifactorial 47-90
Chromosomal 1.9-6.2
increased susceptibility tosomeformsofheartdisease, diabetes,
or cancer (11).
In a study by Baird et al. (4) with a sample ofmore than 1
millionconsecutive livebirths, almost8% developed some type
of genetically based disease before age 25. In a study on the
human health impact of351 Mendelian disorders compatible
withsurvivalbeyondearlychildhood, Costaetal. (9)foundthat
25% ofthedisorders wereapparentatbirthandmorethan90%
bytheendofpuberty. Inaddition, lifespan was reducedin57%
ofthedisorders, andreproductivecapacity wasimpairedin69%.
Treatment prognosis was found to be poor for most of these
disorders, withonly 10-15% ofthephenotypesexhibitingsignifi-
cantimprovement in response to treatment (12).SHELBYETAL.
Likewise, the impactofchromosomal disorders issevere, and
prognosis following medical treatmentispoor. Ofallrecognized
pregnancies (> 5 weeksgestation), 15% are lostbefore term;
as many as 50% oftheseconceptuses havedetectable chromo-
some anomalies (13) (Table 3). Loss of conceptuses before
recognized pregnancy, which isestimated tobe 30-50% (14),
is likelytoinvolveahighfrequency ofchromosomal anomalies.
The total contribution ofde novo mutations tothe incidence
ofgenetic disease is notwell established but, inthecaseofdomi-
nant or X-linked disorders, it is possible to determine if the
mutation was preexisting or newly arisen. In addition, most
chromosomeanomalies thatare lethalorcauseinfertility areob-
viously notpreexisting. Basedonareviewoftheliterature, ithas
beenestimated that 81 % ofall chromosome abnormalities and
20% ofsingle gene disorders are due to de novo mutations in
reproductive cells (11,15). In a more recent examination of
1549 malformed infants of 20 weeks gestation or greater,
Nelson and Holmes (6) found that of the 48 malformations
resulting fromidentifiable singlemutantgenes (i.e., autosomal
dominant, autosomal recessive and X-linked traits), 44% were
due to a presumed new mutation (Table 4).
The scientific evidence thatexposure toenvironmental mut-
agens can induce mutations in both somatic and germinal
Table3. Conception lossandcytogeneticabnormalities inrecognizedhuman
pregnancies (7,11).
% oflost conceptions with
Gestational age, weeks % Conceptions lost cytogeneticabnormality
5-7 6.3 17.5
8-11 3.3 50.6
12-15 2.5 47.0
16-19 1.0 32.8
20-27 1.4 10.7
Stillborn 1.0 5.7
Liveborn 0.6
Neonatal death 5.4
Death < 12 months 6.9
Childhood death 7.4
Table 4. Incidence ofmalformations among69,277 infants ofat least
20 weeks gestational age (6).
Origin Cases/1000 (% ofmalformations)
Genetic causes 11.34 (50.7)
Chromosomal 2.27
Nonchromosomal 9.08
Single gene 0.69
Autosomal dominant 0.30
Presumed new mutation 0.14
Affected parent 0.16
X-linked 0.07
Presumed new mutation 0.01
Affected parent 0.06
Autosonal recessive 0.14
Presumed new mutation 0.07
Affected parent 0.07
Uncertain pattern 0.17
Familial 3.25
Multifactorial inheritance 5.14
Other causes
Teratogens 0.71 (3.2)
Uterine factors 0.56 (2.5)
Twinning 0.09 (0.4)
Unknown cause 9.66 (43.2)
tissues is clear. This facthasbeenthoroughly demonstrated in
a variety of organisms, including mammals. Determining
whether the offspring of individuals exposed to germ cell
mutagens will subsequently develop an observable disease is,
however, much more problematic. Unequivocal epidemio-
logicalevidencethatexposuretomutagenicchemicalscanpro-
duce heritable genetic effects in humans is lacking for several
reasons. First, itisdifficulttoidentifyexposedpopulations. Se-
cond, exposurelevelsareoftenlow. Third, thepopulation size
ofpotentially affected offspring is likely to be small. Further,
the factthattheexposedandaffectedindividuals are notofthe
same generation requires more than a routine surveillance
system (16-19).
Forthesereasons, animal modelshavebeenusedtoestimate
theheritableeffectsofenvironmentalmutagens. Avarietyofin
vivo genetic assays havebeen conducted in rodents, including
testsforgermcellmutagenicity onmorethan20chemicals (20).
These tests are supplemented with mechanistic studies to in-
creaseourunderstandingofthemutationprocess. TheNational
Toxicology Program (NTP) has taken a prominent role in the
identificationofgenetic hazards in theenvironment and in the
acquisition ofdatathatareusedby regulatory agencies inasses-
sing genetic risks to human health. For example, NTP-spon-
soredgerm-cellmutagenesisstudieshavebeenresponsible for
the identification of acrylamide as a reproductive hazard
(21-23), anddose-responseanddose-ratedataonethyleneox-
ide have been used by the EPA in their hazard assessment ef-
forts. The evaluation of various aspects of germ-cell
mutagenesis suchasdose, doserate, sex, and straineffects; in-
vestigationsofmutation induction incells such asoocytes and
zygotes; andidentificationofmodelsofhumangeneticdiseases
such as those for j-thalassemia (26,27) and carbonic
anhydrase-2 deficiency (28) areamongthecontributions made
to the understanding of mammalian germ-cell mutagenesis.
Germ cell genotoxicity assays used by the NTP are described
here along with highlights ofresults using those assays.
Mouse Assaysto Study Germ Cell
Mutations
Dominant Lethal Test
Themousedominantlethaltest(DLT) istheprimarytestused
todetectthegeneticeffectsofchemicalsingermcells. Damage
induced inthegenetic materialofthedevelopingmalegermcell
may notaffecttheabilityofresultingspermtofertilizetheovum,
yetcanresultinthedeathoftheconceptusearly indevelopment.
Experimental evidence has shown that the primary class of
genetic damage responsible for dominant lethality is chromo-
somal aberrations and that the death ofthe conceptus results
from an imbalance in the normal chromosomal complement
following cell division (e.g., loss ofchromosome fragments)
(29). In addition to chromosomal aberrations, aneuploid
gametes (having too few or too manychromosomes) may lead
to dominant lethality and hence constitute a second class of
genetic damage that is detectedby this assay.
ThebasicdesignofaDLTinvolvestreatmentofoneparent,
usually themale, withtheagentunderstudy. Treatedand con-
trolmalesarematedwithuntreatedfemales, andtheuterinecon-
tentsoffemales areanalyzed 13-17 daysaftermating toquan-
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titatethe incidence ofliving anddeadimplants. Definitivedomi-
nant lethal effects areevidencedby a significant increaseindead
implants anda concomitant decrease in live implants. Females
may also be used as thetreated parentindominantlethal studies
to assess the genetic effects of chemicals on oocytes. Special
measures must be taken in female dominant lethal tests because
early embryonic survival may be affected by chemical-induced
changes in female reproductive physiology and because ofthe
limitations onthe numbers oflitters and offspring obtained from
treated females. Nonetheless, it is important thatgenetic effects
be assessed in female germcells, especially following the recent
demonstrations offemale-specific germ cell mutagens (30,31).
Becausethe eventdetected inthe DLT isdeathoftheconceptus,
it is clear that the testdoes notassess abiologicalend pointthat
reflects apotential health risk to futuregenerations. Nonetheless,
the DLTplaysakey role ininitial attempts todetermine whether
anagent reaches the germcells and induces geneticdamage. The
induction ofdominant lethality provides clearevidence thatthe
integrity of the germ-cell genetic material has been affected.
Thus, positive results in a dominant lethal study are adequate
basis forconcern that other more serious, heritable effects may
also be induced by the agent under study (20,32).
Heritable Translocation Test
Theheritable translocation test(HTI) isdesigned todetect in-
duced chromosomal damage in germcells resulting in reciprocal
exchanges ofchromosome segments between nonhomologous
chromosomes. Gametesbearing reciprocal translocations nor-
mally are capable offertilization; the resulting offspring have a
complete complement of chromosomes and are viable. The
primary biological effect in the translocation-carrying offspring
is reduced fertility or, in some cases, complete sterility. The ef-
fect on fertility results from abnormalities in the pairing of
homologous chromosomes at the first meiotic division, an event
unique to meiosis. Because the two translocated chromosomes
have no complete homolog, pairing involves more than two
chromosomes and can result in abnormal meiotic segregation.
When chromosomes are distributed into the germ cells, theo-
retically, halfofthe resulting gametes will bear aduplication of
one chromosomal segment (the distal material on one trans-
located chromosome) and a deletion of another (the distal
material on the second translocated chromosome).
As inmostofthe tests ofgerm-cell mutagenicity, either males
or females can be used as the treated parent, but for practical
reasons, the tests are routinely conducted using treated males.
These males are mated tountreated females and theresulting F,
males are mated to identify those that exhibit reduced fertility.
Such males are then assessed cytogenetically to determine ifthe
effect is indeed theresultofatranslocation. In semisterile males,
preparationoftesticular tissue to permit visualization ofchromo-
somes in first-division spermatocytes will reveal translocations
as multivalent chromosome configurations. In fully sterile males
where total disruption of meiosis may preclude cytogenetic
analysis ofspermatocytes, it is necessary to evaluate metaphase
preparations from somatic cells, such as kidney epithelium or
lymphocytes. Duetothe resources (atleast500F1 males should
be screened per dose group) and expertise required to conduct
the HTT, alimited numberoflaboratories routinely conductthe
test. Therefore, a limitedhistorical database exists on the spon-
taneous incidence of heritable translocations in mice. None-
theless, this rare event is estimated to occur spontaneously in
about one in 5000 malegametes.
Morphological Specific Locus Test
The major concern in genetic risk considerations has been
gene mutations inspermatogonial stemcells. The stemcells are
theoriginofgerm cellsthroughoutthemale's reproductive life,
andtheirpermanenceprovidestheonlygerm-cell stagewherein
genetic damage canaccumulate through time andthereby pose
an increasing risk ofgenetic damage to the progeny. Further,
gene mutations are less likely thanchromosomal damage to be
eliminatedbyselectionduringthecelldivisionsofgametogenesis
and are, therefore, moreapttopersisttothemature germ cells.
As shown in Figure 1, matings that occur in week 7 or later
following treatment ofthe male mouse sample sperm that were
inthe spermatogonial stem-cell stage atthe timeoftreatment. By
doing serial matings aftertreatment, onecanthusdeterminethe
germ-cell stage(s) sensitive to the effect ofa test agent.
The mostextensively used method for studies ofmutations in-
duced atspecific loci inmammaliangermcells isthemousemor-
phological specific locus test for visible markers (MSLT)
developed by W.L. Russell in the early 1950s. This test was
developed to assess the germ-cell mutagenicity ofionizing radia-
tion and provided the bulk ofdata usedin radiation genetic risk
analysis. Morerecently, thetesthasbeenusedto study thegerm-
cell mutagenicity ofchemicals.
The basic concept of the MSLT is relatively simple. Seven
genes (or loci) that affect morphological characteristics ofthe
mouse, namely, haircolor, eye color, and ear shape, are assessed
for mutations. In the standard test, males homozygous for the
wild-type alleles ofthese seven genes are treated with the test
agent and then mated to untreated females homozygous for
recessive alleles at the same seven loci. Normal male gametes
produce progeny that are heterozygous at these seven loci and
will have the same wild-type appearance as their sires. Iftreat-
ment has induced mutations that affect the expression ofany of
the seven loci, sperm containing suchmutations will give rise to
offspring that express the phenotype ofthe recessive allele. At
2-4 weeks ofage, progeny are examined for variant appearance;
variants are bred to confirm that the variant phenotype is
genetically based, i.e., is transmitted to the offspring.
The loci studied in these mouse assays are not necessarily
related to loci thataffect murine orhuman health butare assumed
to be representative of other loci in the genome. They were
chosen to provide a convenient measure ofthe frequency with
which mutations are induced by a test agent. The types ofgenetic
damage recovered inthe MSLT include intragenicchanges such
as basepair substitutions, small additions ordeletions ofgenetic
material, anddeletions oflarger segments ofthe DNA that span
one ofthe loci studied along with adjacent DNA that may con-
tain other genes.
Because of the long history of the MSLT, an immense his-
torical database has accumulated on the frequency of spon-
taneous mutations atthe seven loci studied. This database offers
the assay twogreat advantages. By virtue ofthe evidence for low
variability across time, itmitigates the need for large concurrent
controls. Italsoprovides data needed forthedevelopment ofsen-
sitive statistical methods for analysis oftest results.
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FIGURE 1. Approximate relationships betweenthedaysofmating following acute treatment with a testchemical andthe stageofmaleand female germ cells atthe
time oftreatment.
Biochemical Specific-Locus Test
Thebiochemical specific-locus test(BSLT) is similarin many
respects to the MSLT; only the unique characteristics of the
BSLTwillbediscussedhere. Twofeatures maketheBSLT par-
ticularly desirable forgerm-cellmutagenesis studies. First, the
BSLT screens formutations in alargenumberofknown genes,
thereby providing anefficiency that is notavailable inother gene
mutation tests. At present, morethan 30 genes canbescreened
ineach F, animal ascompared with seven genes intheMSLT. In
addition, these genes are distributed throughout the genome,
having been mapped to 15 different chromosomes and,
theoretically, amuchlargernumberofgenescouldbescreened
astechnological developments make suchscreeningfeasible. Se-
cond, many ofthe genes screened in the BSLT are the same as
those that are associated with geneticdisease in humans, again
providing acloser linkbetween rodent testresultsandpossible
human health effects. Mutations recovered in genes that are
related togenetic disease inhumans mayalsoprovideinvaluable
mouse models for human diseases (e.g., Cooley's anemia and
carbonic anhydrase IIdeficiency) and maycontribute tothefur-
therunderstanding andtreatmentofgeneticdiseases. Thus, more
confidence may be placed in the extrapolation of mouse test
results to potential genetic risk in humans.
Two inbred strainsofmice areusedintheBSLTand, as inthe
MSLT, thestandard testinvolves treatmentofmalesfollowedby
mating withuntreated females. TheF, progeny arethenanalyzed
forevidenceofmutations. Bothbloodandkidney tissue aretaken
fromeachF, animal and areusedto preparesamplesthat aresub-
jected toeither starchgelelectrophoresis orisoelectric focusing.
Mutations are detected that affect the electrophoretic char-
acteristics ofdefined protein products.
Contributions toAssessing Genetic
Hazard
Chemical Testing
In meeting the responsibilities of the NTP to increase
the number of chemicals tested for potentially hazardous ef-
fects, the heritable effects program has added significantly to
the number of chemicals for which mammalian germ-cell
mutagenicity data are available. In 10 years, the program has
doubled the number of chemicals tested for the induction of
specificlocusmutationsand, aspresented inTable5; asubstan-
tialnumberofchemicalshasalsobeentestedforothermutational
end points such as dominant lethal mutations and heritable
translocations.
Chemicals have been selected for testing for a variety of
reasons, butthe twoprimary considerations are known human
exposureandresearch-based interest. Ingeneral, chemicals are
not chosen for germ-cell mutagenicity studies unless they are
known to bemutagenic in vitro and have been shown to induce
geneticeffectsinsomaticcellsofrodentsusing mouse or ratbone
marrow cytogenetic assays.
Table 5 summarizes the results of NTP's mammalian germ-
cell mutagenesis studies. Chemicals such as dibromochloro-
propane, ethylene dibromide, and phenol were tested because
of concern for occupational exposures, but showed no
evidence of germ cell mutagenicity, whereas others such as
ethylene oxide, acrylamide, andmethylene bis-acrylamide have
beenshowntoinducehighlevelsofgeneticdamagein germcells.
Withacrylamide, it wasdemonstratedforthefirsttimethatder-
mal exposure could result in induced genetic damage in germ
cells (34).
Several cancerchemotherapeutic agentshavealsobeentested
toprovide animal data to support humanepidemiology studies
that assess thereproductive outcomesofcancer survivors who
have received radiation and/or chemical therapy. Adriamycin,
bleomycin, chlorambucil,melphalan, andplatinol are amongthe
chemotherapeuticchemicalstested todate. Theresults ofthese
studies have been particularly interesting. Chlorambucil and
melphalan were found to be the most potent mutagens ever
discovered inpostmeiotic male germcells. Molecularanalysis
ofthemutationsinducedbytheseandotherchemicalshasreveal-
ed that mutations recovered from germ cells exposed as stem
cells or during later premeiotic stages are almostall small, in-
tragenic changes whereas those induced in later stages are
predominantly deletions ofthe target geneandvarying amounts
offlanking DNA (32).
Threeotherchemotherapeutic agents, adriamycin, bleomycin,
andplatinol, havebeen shown to induce dominant lethal muta-
tions infemale germcells, butshow nosucheffectinmales. Both
therelationbetweengerm-cell stageandmolecular lesions and
thedemonstrationoffemale-specificeffects areimportant con-
siderations in thedesignand interpretation ofepidemiological
studies relating chemotherapy and reproductive outcomes.
[Dayof Mating } E 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 2728 29 30 31 32 33 34 35 36 37 38 39 40 4142 43 Later
Following Treatment ;g
Male [Mature - Spermatids - - Spermatocytes DifferentiatedJ L Spermatogonial Sperm Spermatogonia Stem CetIs
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Tbble 5. Sumnary ofresults from National Tokicology Program mouse germcell mutagenicity studies.
Dominant lethal Heritable Specific locus
Chemicals Male Female Referencea translocations Reference Postmeiotic Premeiotic Reference
2-Acetylaminofluorene - (33)
4-Acetylaminofluorene - (33)
Acrylamide + - Unpublished; (21,34) + (22) + - (23)
Adriamycin - + (35) _b Unpublished
3-Azido-3-deoxythymidine - - Unpublished
Benzo(a)pyrene + (33)
Bleomycin - + (36) -b Unpublished
Chlorambucil + Unpublished + + - (37)
Corn oil - - (38)
Dibromochloropropane - - (39) - - (40)
Diethyl sulfate - (41)
Dimethyl sulfate + - Unpublished; (41) + Unpublished
Divinyl sulfone (42)
Ethylenebisacrylamide + Unpublished + Unpublished
Ethylene dibromide - (43) - Unpublished; (43)
Ethylene oxide + + (41,44) + (45) + - (46,47)
Ethylnitrosourea + + (48) + (48) + (32)
Hexamethylphosphoramide - + Unpublished - Unpublished
Hycanthone - + (31)
Melphalan + Unpublished + Unpublished + + (49)
6-Mercaptopurine + (50) - (50) - - (50)
Methylmethane sulfonate - (41)
Methylnitrosourea + (48) + (48) + + (51)
Methylvinyl sulfone - (42)
Methylenebisacrylamide + (52) + (52)
Nocodazole - (53)
Phenol - Unpublished
Platinol - + (30) - - Unpublished
Pyrene - (33)
Tetrahydrocannabinol - (54) - (54)
Urethane - (55) - - (55)
aUnpublished test results.
bResults fromtreated females.
Effects on Male Postmeiotic Germ Cells
Spermatogonial stemcells arethegermcellsofgreatest con-
cern for genetic risk because they constitute a permanent,
dividing-cell population that can accumulate induced genetic
damagethroughoutthe reproductive lifeofthemale. Subsequent
germ-cell stages, suchasdifferentiating spermatogonia, sperma-
tocytes, spermatids, andspermatozoa, areall transientandthus
canonly accumulategeneticdamageoverarelativelybriefperi-
od. However, because itwas knownthat somegerm-cell muta-
gens exhibittheirpeak mutagenic activity in postmeiotic germ
cell stages, it was decided early in thedevelopmentofthis pro-
gramtoevaluatebothpre-andpostmeioticgerm-cell stages for
inducedmutations. Thetestingofchemicals formutagenicity in
postmeiotic germcell stagespermitstheidentification ofchemi-
cals that were only mutagenic in these stages, an important
consideration whenevaluating the genetic riskassociated with
continuous or recurrent exposures of reproductively active
individuals.
As can be seen in Table5, several chemicals have been iden-
tifiedthataresolely orprimarilymutagenic inpostmeiotic stages
ofspermatogenesis. In fact, with the exception ofmelphalan,
chemicals ofenvironmental significance that havebeen shown
tobemalegerm-cell mutagensarespecific forpostmeioticgerm-
cell stages. These include chemicals such as acrylamide and
ethyleneoxidethat arepresent inoccupational environments as
well as chemotherapeutic agents suchas chlorambucil.
Expansion ofTest Systems
Although the MSLT, BSLT, DL, and HT have provided a
wealthofinformationtowardtheidentificationandcharacteriza-
tion ofmammalian germ-cell mutagens, each is limited in the
types ofmutations detected and inthe relevanceofthese muta-
tions tohealth effects in the firstgeneration following mutagen
exposure. Inanefforttoovercome someoftheselimitations, two
projects were recently initiated to expand the classes ofmuta-
tional events recovered by an assay.
Thefirst isacombinedendpointassay basedontheBSLT. It
retains the desirable characteristics ofthis systemwhile incor-
poratingothermutational endpointsthatcanbedetected inthe
same progeny (56). In this system, progeny are screened for
dominant morphological variation, recessive morphological
variation, and dominantcataracts. The system is thusdesigned
to detect abroader rangeofinduced genetic variants including
both dominant and recessive mutations in both selected and
unselected genes. Byobtaining moreinformationfromeach F,
mouse, moreeffective useismadeoftheexperimental animals,
andthe resulting data shouldprovide aclearer indicationofthe
overall genetic riskassociated withexposure tothetestchemical.
Inaddition, effortsareunderway todetectinducedDNAdamage
suchasinsertions, deletions, andrearrangementsthroughtheuse
ofDNA probes for repetitive DNA sequences.
Thesecond system isbasedonthe MSLT. Theassessmentof
dominant damage system (57) employs several indicators of
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inducedgeneticdamageexpressed inthefirstgenerationfollow-
ing exposure. These indicators are all associated with survival
or impaired health or fitness in the offspring. They include
cataracts, skeletal abnormalities, litter sizes, and survival to 11
weeks. Usingthegerm-cell mutagensX-rays, ethylnitrosourea,
and chlorambucil, preliminary experiments arebeing conducted
todeterminetheinducedfrequenciesofdominanteffectsrelative
to recessive mutations detected in the MSLT.
Effects ofZygote Exposures
Ina seriesofexperiments conducted todeterminetheeffects
of germ-cell mutagens on the zygote, it was discovered that
chemicalexposureofthepronuclear-stagezygotecouldresultin
a range ofdevelopmental abnormalities distinct from what is
observed following either treatment of germ cells or of the
developing embryo or fetus (44,58). Preliminary evidence in-
dicates that these effects may not be the result of gene or
chromosomalmutation, andithasbeenspeculatedthattheymay
result from phenomena such as the induction oftransposable
elements ordisruption ofnormal generegulation(59). Results
presented inTable6 showthatthesezygote-exposure effects are
mutagen specific.
Although the sevenchemicals included inTable6inducehigh
frequencies of early deaths (deciduomata or "resorption
moles"), thereisadichotomy withregardtofrequencyofinduc-
edmid-and lategestationdeaths. Ethyleneoxide, ethylmethane
sulfonate, dimethyl sulfate, anddiethyl sulfate induce high fre-
quencies ofmid- and lategestation deaths, and among the sur-
viving fetuses there isanotably high incidenceofdevelopmen-
tal abnormalities. With the other three chemicals (methyl-
methane sulfonate, ethylnitrosourea, and trimethylene mel-
amine)earlydeathsareinducedbuttheincidenceofmid-andlate
gestation deaths and the proportion oflive fetuses with abnor-
malitiesarelow. Inadditiontodefiningtheuniquemutagen sen-
sitivity ofanearly developmental stageofthe conceptus, these
studies offer a promising opportunity to elucidate, at the mo-
lecularlevel, geneticandepigeneticprocessesrequiredfornor-
mal mammalian development.
Female-Specific Effects
In the course ofourdominant lethal studies, four chemicals
were identified thatappear toinducegenetic damageinoocytes
butnot inmalegermcells(Table5). Theuniquevulnerabilityof
female germ cells to genetic damage by hycanthone, platinol,
adriamycin, andbleomycinemphasizes theneedtodirectmore
efforttowardassessinginducedgeneticdamageinfemalegerm
cells as wellas the importanceofincorporating data from such
studies into assessmentsofgenetic risk.
The Future
In recent years, technical advances have provided efficient
methods for molecular analysis ofmutations in defined target
genes (61). The polymerase chain reaction (PCR), DNA se-
quenceanalysis, andtheisolationofmolecularprobestovarious
locihavebeenusedtoefficiently recoverandidentifymutations.
Moststudieshavefocusedontheidentificationofnewmutations
insomaticcells; however, suchtechniquesmayalsobeuseful in
screening formutationsindisease-related genes intheprogeny
ofmutagen-exposed individuals. The limitations ofscreening
large numbers ofindividuals for a specific mutational change,
however, have led to thedevelopmentofmethods forassessing
genomic variations thatare notassociated with specific loci.
Thereareseveralpromisingmoleculartechniquesthathavethe
potentialtodetectnewlyarisinggeneticchangesandtherebyto
provide insight into the etiology of spontaneous or induced
humangeneticdisease. Thesetechniques includea) application
ofchromosome-specific fluorescent probes, b) identification
and screening of hypervariable regions of the mammalian
genomeusing probes forrepetitive DNA sequence, and c) the
useofPCRandstandardnucleic-acidblottingtechniques. These
procedures arenotlimitedtoelucidationofchanges inspecific
genesbutcanbeusedtoidentifychangesthatmightoccurover
alargeportionofthegenomeasaresultofagermlinemutation.
Experimental approaches already in use in defining germline
variationincludetheuseofchromosomespecificprobestoiden-
tifyaneuploidies, Southern blotanalysis ofgenomicinsertions,
deletions, and rearrangements (I/D/R; 62), and assessment of
meiotic recombination asdetectedby PCRinindividual human
sperm cells (63). Someofthesetechniques as well as methods
for determining locus specific variation, have been reviewed
recently (64).
Probes specific for each ofthe 24 human chromosomes are
rapidly becoming available. Such probes can be tagged with
fluorescentreportermolecules, andthesiteofhybridization(and
thereforethechromosomeofinterest) canbeobserveddirectly
by fluorescence microscopy. This approach to identifying
specific human chromosomes has been used widely in human
genemappingstudiesandisbeingdevelopedforuseindetection
ofchromosomalgainorlossinindividualspermcells. Suchpro-
ceduresmaybeusefulindeterminingtheincidenceofaneuploidy
in occupationally or environmentally exposed individuals. A
Table 6 Summary ofresults fromtreated zygoteexperiments.'
Testchemical, dose
Ethylene oxide, 1200 ppm
Ethylmethane sulfonate, 250mg/kg
Diethyl sulfate, 150mg/kg
Dimethyl sulfate, 25 mg/kg
Methylmethane sulfonate, 75 mg/kg
Ethylnitrosourea, 75 mg/kg
Triethylene melamine, 1.2 mg/kg
Controlb
aExposure offemales 6 hrafter mating.
"A typical control.
% Early deaths
53
31
24
57
25
49
57
3.6
% Mid- and late
gestationdeaths
29
31
37
11
2.5
2.0
2.2
1.2
% Live fetuseswith
abnormalities
37
29
24
25
3.8
15
10
0.6
Reference
(44,60)
(28,44)
(41,60)
(41,60)
(41,60)
(44)
(44)
(41)
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similarsetofprobes specificforeachofthemousechromosomes
iscurrently being isolatedandcharacterized. Thesewillpermit
laboratory studies to be conducted using animals treated with
selectedchemicals anddose levels sothatobservations made in
humans can be extended or confirmed.
DNA hybridization techniques have been proposed for the
studyofgenomicI/D/R(62). TheI/D/Rtechniqueusesavariety
of probes that may hybridize to repetitive sequences, hyper-
variable regions, orspecificgenesandpseudogenes. Experimen-
tally, all oftheprobes areusedtodetectalterations inhybridiza-
tion patterns following Southern blotting of genomic DNA.
These techniques allow the detection of large-scale genomic
alterations. Once again, such studies can be applied to human
populations and similarI/D/R studiesareunderwaytoassess in-
duced rearrangements in mice.
Likewise, DNA probes to linked genes can be used as PCR
primers to detect meiotic recombination events (63). Specific
genetic sequences inindividual spermcanbescreenedandvaria-
tions can be quantitated, thus providing a measure ofmeiotic
recombination frequencies incontrol andexposedpopulations.
Similarprobes canbeusedtoquantitate meiotic recombination
frequencies in mice or other experimental organisms.
Methods forproducingandstudyingtransgenic animalscom-
priseanotheremerging technologythatcanbeappliedtostudies
ofinduced heritable effects. Itis nowpossibletoconstructtran-
sgenicanimalmodelsthatcarry specific genesoranaltered(or
modified) genetic background to allow the study of induced
mutations in vivo. At least three transgenic mouse models for
detectingpointmutationsinvivoareatvariousstagesofdevelop-
ment. All use bacterial genes that have been inserted into the
mousegenomes asmutationtargets. Theseprovideaconvenient
meanstostudytheinductionofmutationsindifferenttissues, in-
cludingthegermcells, ofanexperimental animal. Twobacterial
genes, lacZ(65)andlacI(66)havebeenusedastargets forfor-
ward mutations. Bothprovidecolorometricassays formutations.
Thus, transgenic miceusedintheseassayscanbetreatedwitha
testchemical, andafteraperiodtoallowforDNArepairandfix-
ationofany newmutations, differentorganscanberemovedand
the DNApreparedfortherecovery ofXphagecarrying mutated
lac ZorlacIgenes. Mutations areidentifiedbythecolorofin-
dividual plaques following infection ofE. coli and the precise
natureofthemutationcanthenbedeterminedby sequencingthe
target gene. The third transgenic mouse system has been
developed to detect reversion mutations ofan amber codon of
bacteriophage I'X174. Inthis system, 4LX174 is recovered from
the mousegenome, andmutationsaredetectedbytheirabilityto
form plagues on anE. colihost (67).
All the techniques discussed above have the ability to detect
genetic variation inprogeny ascomparedtotheparental genera-
tion, andmanyofthesetechniques maybenoninvasivelyapplied
tocohortsofmutagen-exposedpopulations. Thus, suchtechni-
ques provideabasis forthedevelopmentofsensitiveassays for
newly inducedgermlinemutations. Routineuseofthesemethods
to screen forinduced genetic effects will, however, requiread-
ditional development and experimental validation. Any clear
associationbetweenchemically inducedchanges inthehuman
genomeandspecific environmental exposures willlikelyrequire
the development ofparallel animal assays. Data derived from
molecular genetic studies in humans, along with verifiable
methods to extrapolate from corresponding animal data, will
permitamoreinformedassessmentofthebiologicalandmedical
consequencesofmutagenexposure. Withoutsuchcomparative
data, extrapolation fromanimaldatatoestimatesofthegenetic
riskforhumans willbedifficult. Continuedanimalstudies, with
greateremphasisontheuseofmoleculartechniquestodetectand
characterizemutantsandelucidate thestructureandfunctionof
the genome are needed to increase our understanding of the
mutational process in mammals and to improve our ability to
assess genetic risk.
Collaborations are being developed within and outside of
NIEHS to pursue thedetection ofinduced mutations in human
germ cells while refining methods that permit detection ofthe
similareffectsinmice. Further, studiestodeterminetheeffectsof
inducedgerm-cellmutationsontumorfrequenciesinsubsequent
generationsandtoinvestigatenovelprocessessuchastheinduc-
tionofmobilegeneticelementsandalterationsofgeneticimprint-
ingthatinfluencemammalianheritableeffectswillbepursued.
TheNTP-sponsored experimental workpresentedanddiscussed inthispaper
was conducted by agroupofextraordinarily dedicated andcapable mammalian
geneticists. Theauthors expresstheirsinceregratitude totheseresearchers who
include L.B. Russell, W.L. Russell, W.M. Generoso, S.B. Lewis, and G. Sega.
The work was sponsored by the NIEHS under interagency agreements
YO1-ES-10067 andYO1-ES-20085 withtheU.S. DepartmentofEnergy andunder
contract NO1-ES-95273 with Research Triangle Institute.
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